PDCD1 and cancer: Taken together, the in vivo activity of cordycepin in augmenting anti-PD1 efficacy may be mediated by various effects, including anti-cancer [32], immunomodulatory [11], and suppressive effects on NK-A2AR and NK-A2BR expression.